Latest Dana-Farber Cancer Institute News

She is awarded the Sjöberg Prize for laying the foundations of a cancer vaccine
Great minds tackle brain cancer puzzle at International Summit
Tagrisso with the addition of chemotherapy approved in the US for patients with EGFR-mutated advanced lung cancer
Tagrisso with the addition of chemotherapy approved in the US for patients with EGFR-mutated advanced lung cancer
Strongest contender in decades in fight against breast cancer
Research reveals how disordered proteins contribute to the properties of the rabies virus
Research brings better understanding of how disordered proteins contribute to the properties of the rabies virus
Enhertu demonstrated strong and durable tumour responses in previously treated HER2-mutant advanced lung cancer in DESTINY-Lung02 Phase II trial
Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months in EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial
Ludwig Harvard study uncovers role of ultraviolet radiation in the development of a rare leukemia in the skin
Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial
Christopher Walsh, esteemed Ludwig scientific advisor, passes away at age 79
AstraZeneca showcases strength of haematology portfolio and pipeline across multiple hard-to-treat conditions
Study sheds light on precancerous ‘clonal outgrowth’ in blood cells
New molecular subset of pediatric liver cancer identified
Cell division finding could lead to new cancer treatments
U.S. Multisociety Task Force on Colorectal Cancer releases new recommendations for harmartomatous polyposis syndrome
BICRA gene provides answers to patients, doctors and scientists
Experts release new management strategies for malignant colorectal polyps
Ludwig Harvard Co-Director George Demetri wins Karnofsky Award